Log in or Sign up for Free to view tailored content for your specialty!
Interstitial Lung Disease News
Efzofitimod safe, may improve clinical outcomes in patients with sarcoidosis
Among patients with pulmonary sarcoidosis, efzofitimod was safe through 24 weeks, and it improved measures of lung function and quality of life when given at a higher dosage, according to study results published in CHEST.
Concurrent PAH-ILD occurs in 7% of patients with systemic sclerosis
Approximately 7% of patients with systemic sclerosis in an Australian cohort demonstrated concurrent pulmonary arterial hypertension and interstitial lung disease, according to data published in Arthritis Research & Therapy.
Log in or Sign up for Free to view tailored content for your specialty!
Inhaled treprostinil safe, improves outcomes in pulmonary hypertension-ILD over 1 year
Inhaled treprostinil was safe in patients with pulmonary hypertension associated with interstitial lung disease over 1 year and sustained improved exercise capacity, according to study results published in European Respiratory Journal.
Familial interstitial pneumonia links to pulmonary fibrosis risk in asymptomatic relatives
For individuals related to someone with familial interstitial pneumonia, the prevalence of pulmonary fibrosis was around 1,000 per 100,000 person-years, according to study results.
High renal crisis, interstitial lung disease prevalence with systemic sclerosis sine scleroderma
Dermatologists should be aware of cutaneous findings in patients with systemic sclerosis sine scleroderma due to the association of internal organ dysfunction, according to a study.
Female patients with Sjögren’s syndrome more like to exhibit eye symptoms than males
There are several differences in the symptoms reported among male and female patients with primary Sjögren’s syndrome, according to data published in the Journal of Clinical Rheumatology.
Ziritaxestat fails to improve lung function in patients with idiopathic pulmonary fibrosis
WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.
Q&A: Protecting patients with respiratory diseases during wildfire outbreak
People residing in the East Coast are currently experiencing poor air quality due to smoke and haze from hundreds of wildfires in Canada.
High levels of air pollution linked to ILD prevalence, acute exacerbations, death
WASHINGTON — Exposure to air pollutants at high levels contributed to interstitial lung disease incidence, acute exacerbations and death, according to an abstract presented at the American Thoracic Society International Conference.
Sarcoidosis diagnostic scores have ‘good to excellent’ discriminatory ability
The ability to discern sarcoidosis from other diagnoses was “good to excellent” in two sarcoidosis diagnostic scores, according to results published in Annals of the American Thoracic Society.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read